Liz Shea | Head, IR |
Rick Gonzalez | Chairman and CEO |
Rob Michael | Vice Chairman and President |
Jeff Stewart | EVP and Chief Commercial Officer |
Tom Hudson | SVP R&D, and Chief Scientific Officer |
Carrie Strom | SVP, and President, Global Allergan Aesthetics |
Neil Gallagher | VP and Chief Medical Officer |
Roopal Thakkar | Vice President, Global Regulatory Affairs |
Andrew Baum | Citi |
Terence Flynn | Morgan Stanley |
Mohit Bansal | Wells Fargo |
Gary Nachman | BMO Capital Markets |
Chris Schott | J.P. Morgan |
Steve Scala | Cowen |
Chris Raymond | Piper Sadler |
Tim Anderson | Wolfe Research |
Geoff Meacham | Bank of America |
Colin Bristow | UBS |
Chris Shibutani | Goldman Sachs |
David Risinger | SVB Securities |
Good morning and thank you for standing by. Welcome to the AbbVie Second Quarter 2022 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion of this call. [Operator Instructions] I would now like to introduce Ms. Liz Shea, Vice President, Head of Investor Relations.